Try our beta test site
42 studies found for:    Open Studies | "Testicular Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Testicular Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Testicular Vascular Evaluation in Patients Undergoing Inguinal Hernia Repair
Conditions: Inguinal Hernia;   Testicular Diseases
Intervention: Diagnostic Test: Ecocolordoppler ultrasound testicular evaluation
2 Not yet recruiting One Stage vs. Two Stage Gubernaculum Sparing Laparoscopic Orchidopexy: A Randomized Controlled Trial
Condition: Intraabdominal Undescended Testes
Interventions: Procedure: Two-Stage GSLO Technique;   Procedure: One-Stage GSLO Technique
3 Not yet recruiting Comparison Between the Clinical Assessment of the Undescended Testis and Its' Ultrasonographic Size
Condition: Comparing the Difference Between the Manual and the Ultrasonographically Evaluation of the Undescended Testicular Size
Intervention: Other: testicular ultrasound
4 Recruiting Orchidopexy Randomized Clinical Assessment
Condition: Unilateral Cryptorchidism
Interventions: Procedure: Single-stage Fowler-Stephens orchidopexy (FSO);   Procedure: Two-stage Fowler-Stephens orchidopexy (FSO)
5 Recruiting Expertise-Based Randomized Controlled Trial of Scrotal Versus Inguinal Orchidopexy on Post-operative Pain
Condition: Low-lying Unilateral Palpable Undescended Testis
Interventions: Procedure: Scrotal Orchidopexy;   Procedure: Inguinal Orchidopexy
6 Recruiting Evaluating Pain Outcomes of Caudal vs Ilioinguinal Nerve Block in Children Undergoing Orchiopexy Repair
Conditions: Testicle Undescended;   Pain, Postoperative
Interventions: Procedure: Ilioinguinal/iliohypogastric nerve block;   Procedure: Caudal-epidural nerve block;   Drug: Acetaminophen;   Drug: Sevoflurane;   Drug: Remifentanil;   Drug: Propofol;   Drug: Morphine;   Drug: Ondansetron;   Drug: Dexamethasone;   Drug: Ketorolac;   Drug: Ropivacaine
7 Not yet recruiting Development of Diagnostics and Treatment of Urological Cancers
Conditions: Prostate Carcinoma;   Kidney Cancer;   Urothelial Carcinoma;   Testicular Cancer;   Penile Cancer
Intervention: Other: Personalised treatment
8 Recruiting Study of Testosterone vs Placebo in Testicular Cancer Survivors
Conditions: Metabolic Syndrome;   Testicular Cancer;   Leydig Cell Failure in Adult
Interventions: Drug: Testosterone;   Drug: Placebos
9 Not yet recruiting MED-C Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Conditions: Neoplasms;   Lung Neoplasms;   Colon Neoplasms;   Breast Neoplasms;   Pancreatic Neoplasms;   Prostate Neoplasms;   Kidney Neoplasms;   Liver Neoplasms;   Rectal Neoplasms;   Hematologic Neoplasms;   Multiple Myeloma;   Myelodysplastic Syndromes;   Ovarian Neoplasms;   Bladder Neoplasms;   Testicular Neoplasms;   Endometrial Neoplasms;   Brain Neoplasms;   Biliary Tract Neoplasms;   Head and Neck Neoplasms;   Uterine Cervical Neoplasms;   Skin Neoplasms;   Melanoma;   Gastric Neoplasms;   Anal Neoplasms;   Sarcoma
Intervention: Other: Provider determined
10 Recruiting The Platinum Study Comparison Group
Condition: Testicular Neoplasms
Intervention: Behavioral: Questionnaire
11 Recruiting Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
Condition: Testicular Cancer
Interventions: Drug: Veliparib;   Drug: Gemcitabine;   Drug: Carboplatin
12 Recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Conditions: Acinar Cell Carcinoma;   Adrenal Cortex Carcinoma;   Adrenal Gland Pheochromocytoma;   Anal Canal Neuroendocrine Carcinoma;   Anal Canal Undifferentiated Carcinoma;   Appendix Mucinous Adenocarcinoma;   Bladder Adenocarcinoma;   Bronchioloalveolar Carcinoma;   Cervical Adenocarcinoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Cholangiocarcinoma;   Chordoma;   Colorectal Squamous Cell Carcinoma;   Endometrial Adenocarcinoma;   Endometrioid Adenocarcinoma;   Esophageal Neuroendocrine Carcinoma;   Esophageal Undifferentiated Carcinoma;   Extrahepatic Bile Duct Carcinoma;   Fallopian Tube Adenocarcinoma;   Fibromyxoid Tumor;   Gastric Neuroendocrine Carcinoma;   Gastric Squamous Cell Carcinoma;   Giant Cell Carcinoma;   Intestinal Neuroendocrine Carcinoma;   Intrahepatic Cholangiocarcinoma;   Lung Carcinoid Tumor;   Lung Sarcomatoid Carcinoma;   Major Salivary Gland Carcinoma;   Malignant Odontogenic Neoplasm;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Skin Neoplasm;   Malignant Testicular Sex Cord-Stromal Tumor;   Metastatic Malignant Neoplasm of Unknown Primary Origin;   Mixed Mesodermal (Mullerian) Tumor;   Mucinous Adenocarcinoma;   Mucinous Cystadenocarcinoma;   Nasal Cavity Adenocarcinoma;   Nasal Cavity Carcinoma;   Nasopharyngeal Carcinoma;   Nasopharyngeal Papillary Adenocarcinoma;   Nasopharyngeal Undifferentiated Carcinoma;   Oral Cavity Carcinoma;   Oropharyngeal Undifferentiated Carcinoma;   Ovarian Adenocarcinoma;   Ovarian Germ Cell Tumor;   Ovarian Mucinous Adenocarcinoma;   Ovarian Squamous Cell Carcinoma;   Pancreatic Acinar Cell Carcinoma;   Pancreatic Neuroendocrine Carcinoma;   Paraganglioma;   Paranasal Sinus Adenocarcinoma;   Paranasal Sinus Carcinoma;   Parathyroid Gland Carcinoma;   Pituitary Gland Carcinoma;   Placental Choriocarcinoma;   Placental-Site Gestational Trophoblastic Tumor;   Primary Peritoneal High Grade Serous Adenocarcinoma;   Pseudomyxoma Peritonei;   Scrotal Squamous Cell Carcinoma;   Seminal Vesicle Adenocarcinoma;   Seminoma;   Serous Cystadenocarcinoma;   Small Intestinal Adenocarcinoma;   Small Intestinal Squamous Cell Carcinoma;   Spindle Cell Neoplasm;   Squamous Cell Carcinoma of the Penis;   Teratoma With Malignant Transformation;   Testicular Non-Seminomatous Germ Cell Tumor;   Thyroid Gland Carcinoma;   Tracheal Carcinoma;   Transitional Cell Carcinoma;   Undifferentiated Gastric Carcinoma;   Ureter Adenocarcinoma;   Ureter Squamous Cell Carcinoma;   Urethral Adenocarcinoma;   Urethral Squamous Cell Carcinoma;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma, Not Otherwise Specified;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Procedure: Biospecimen Collection;   Biological: Ipilimumab;   Biological: Nivolumab
13 Recruiting Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST)
Condition: Stage II A/B Seminomatous Germ Cell Tumors
Intervention: Procedure: Primary retroperitoneal lymph-node dissection (pRPLND)
14 Recruiting Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
Conditions: Germ Cell Tumors;   Testis Cancer;   Testicular Cancer;   Embryonal Carcinoma;   Nonseminomatous Germ Cell Tumor
Intervention: Drug: Brentuximab Vedotin
15 Recruiting Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor
Condition: Testicular Germ Cell Tumor
Intervention: Other: EORTC QLQ-CIPN20
16 Recruiting Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Partners; A Pilot Study
Conditions: Breast Cancer;   Testicular Cancer
Intervention: Other: Literature search and semi-structured interview
17 Recruiting Vascular Fingerprint Validation Study
Condition: Testicular Cancer
Intervention:
18 Recruiting Health Status and Burden of Late Effects in Very Long-term Testicular Cancer Survivors (STANDBY-study)
Condition: Testicular Cancer
Intervention:
19 Recruiting Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy
Conditions: Peripheral Nervous System Diseases;   Testicular Neoplasms
Interventions: Procedure: Blood sample collection;   Behavioral: Report of peripheral neuropathy after cisplatin therapy
20 Recruiting Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer
Condition: Testicular Cancer
Intervention: Drug: cabazitaxel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.